![]() |
市場調查報告書
商品編碼
1899467
乳房X光攝影市場規模、佔有率和成長分析(按類型、產品類型、技術、應用和地區分類)-2026-2033年產業預測Mammography Market Size, Share, and Growth Analysis, By Type (Screening Mammography, Diagnostic Mammography), By Product (Film Screen Systems, Digital Systems), By Technology, By End Use, By Region - Industry Forecast 2026-2033 |
||||||
預計到 2024 年,乳房X光攝影市場規模將達到 242 萬美元,到 2025 年將達到 267 萬美元,到 2033 年將達到 576 萬美元,在預測期(2026-2033 年)內,複合年成長率為 10.1%。
乳癌發生率的上升以及對早期檢測需求的增加,正顯著影響乳癌篩檢設備市場。隨著全球人口的成長,尤其是60歲以上女性(她們佔乳癌死亡人數的大多數),有效篩檢的需求變得日益迫切。這一年齡層不僅面臨更高的發病率和死亡率,也凸顯了對先進診斷解決方案的迫切需求。此外,不斷湧現的創新乳房X光攝影技術旨在提升使用者體驗並提高影像精度。傳統的2D乳房X乳房X光攝影由於結構重疊,在影像解讀方面存在挑戰,而新型系統則有望提供更清晰的影像和更卓越的診斷能力,從而彌補乳癌檢測方面的現有不足。
乳房X光攝影市場促進因素
推動乳房X光攝影市場發展的關鍵因素是全球乳癌發生率的上升。乳癌是女性最常見的癌症之一,因此早期發現和積極介入的重要性不容忽視。為此,許多醫療機構和政府部門,尤其是在經濟發達的國家,正在推行旨在提高公眾乳癌意識提升並鼓勵定期篩檢的篩檢計畫。這種對早期發現的日益重視,顯著提升了對先進乳房篩檢技術和服務的需求,最終推動市場發展,並提高了乳房保健服務的可及性和有效性。
乳房X光攝影市場限制因素
乳房X光攝影市場面臨許多限制因素,主要源自於先進的數位和3D乳房攝影乳房攝影技術成本高昂。這些技術需要大量的資金投入,而這種經濟障礙對發展中地區的小規模醫療機構和設施影響尤為顯著,阻礙了它們採用必要的技術。因此,資源有限的地區限制了乳房X光檢查技術的普及和市場成長。儘管乳房篩檢技術取得了顯著進步,但購買和維護這些先進系統的持續成本仍然是市場擴張和提高可及性的重要障礙。
乳房X光攝影市場趨勢
將人工智慧 (AI) 應用於乳房篩檢流程是目前乳房X光攝影市場的一大趨勢。這項轉變的驅動力在於提高診斷準確性的需求,因為人工智慧工具能夠輔助放射科醫生檢測出傳統評估方法可能遺漏的細微異常。人工智慧輔助乳房X光檢查能夠更快、更精確地分析乳房X光影像,從而提高早期檢出率並最大限度地減少人為誤差。隨著醫療機構積極採用這項技術,市場將持續發展,整合更先進的人工智慧系統,最終徹底改變乳癌篩檢和診斷領域。
Mammography Market size was valued at USD 2.42 Million in 2024 and is poised to grow from USD 2.67 Million in 2025 to USD 5.76 Million by 2033, growing at a CAGR of 10.1% during the forecast period (2026-2033).
The rising incidence of breast cancer, coupled with a growing demand for early detection, is significantly influencing the market for breast cancer screening devices. As the global population expands, particularly among women aged 60 and older-who represent a substantial percentage of breast cancer fatalities-the necessity for effective screening is becoming increasingly urgent. This demographic not only exhibits high rates of both incidence and mortality but also highlights a pressing need for advanced diagnostic solutions. Furthermore, the continuous introduction of innovative mammography technologies aims to enhance user experience and improve imaging accuracy. While traditional 2D mammography presents challenges in interpreting images due to overlapping structures, newer systems promise clearer imaging and better diagnostic capabilities, addressing the existing gaps in breast cancer detection.
Top-down and bottom-up approaches were used to estimate and validate the size of the Mammography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Mammography Market Segments Analysis
Global Mammography Market is segmented by Type, Product, Technology, End Use and Region. Based on Type, the market is segmented into Screening Mammography, and Diagnostic Mammography. Based on Product, the market is segmented into Film Screen Systems, Digital Systems, Analog Systems, and 3D Systems. Based on Technology, the market is segmented into Breast Tomosynthesis, CAD Mammography, and Digital Mammography. Based on End Use, the market is segmented into Hospitals, Specialty Clinics, Diagnosis Centers, Others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Mammography Market
A significant factor propelling the growth of the mammography market is the rising prevalence of breast cancer worldwide. As one of the most frequently diagnosed cancers among women, the importance of early detection and proactive measures cannot be overstated. Consequently, numerous healthcare organizations and governmental bodies are implementing screening initiatives to promote breast cancer awareness and encourage regular screenings, particularly in more affluent nations. This heightened focus on early detection has fostered a substantial demand for advanced breast screening technologies and services, ultimately driving the market forward and enhancing the accessibility and effectiveness of breast health management.
Restraints in the Mammography Market
The mammography market faces notable restraints primarily due to the high costs associated with advanced digital breast imaging and 3D breast imaging technologies, which require substantial capital investments. This financial barrier particularly impacts smaller healthcare organizations and facilities in developing regions, hindering their ability to adopt these necessary technologies. As a result, the potential for widespread utilization and market growth is restricted, especially in areas where funding is limited. Despite the significant advancements in breast screening technology, the ongoing expenses related to purchasing and maintaining these sophisticated systems remain a critical obstacle for broader market expansion and accessibility.
Market Trends of the Mammography Market
The mammography market is currently witnessing a significant trend towards the integration of Artificial Intelligence (AI) in breast screening processes. This shift is driven by the need for enhanced diagnostic accuracy, as AI tools assist radiologists in detecting subtle abnormalities that might be missed during traditional evaluations. With AI-assisted mammography, the analysis of mammogram images becomes faster and more precise, thereby improving early detection rates and minimizing the potential for human error. As healthcare providers increasingly adopt this technology, the market is evolving to incorporate advanced AI systems, ultimately transforming the landscape of breast cancer screening and diagnosis.